Yesterday, the Chief Financial Markets Regulator approved merging of Deutsche Boerse as well as NYSE Euronext (NYX).
The Federal Financial Supervisory Authority of Germany, BaFin has approved barter deal which was agreed earlier in February. In a statement, Deutsche Börse said that an evaluation, identical to investigates of shareholder control carried out by the authorities of the stock exchange.
On the other hand, representatives of exchange which is based in Frankfurt said: “BaFin’s overall conclusion was that there are no grounds against the merger in Germany in terms of banking supervisory regulations”. Earlier in July, NYSE Euronext as well as Deutsche Börse has successfully implemented policies to reserve some support from the shareholders. However, the Chief Operating officer of NYSE Euronext, Lawrence Leibowitz has declined any information regarding any deal yesterday.
On Friday, a group of media people has insisted that European antitrust authorities attempted to negotiate with regional market regulators as an attempt to efficiently deal with various competitive issues pinpointed by NYSE Deutsche Börse. Simultaneously, a Spokesperson of the EU Competition Commission has hailed media persons, and notified about continuous investigations.
However, sources have revealed that the deal seeks an approval from European antitrust authorities.
There are a lot of things not going right at the IRS and mostly so when it comes to filing for Earned Income Tax Credits (EITC).
In December 2014, a report by Watchdog.org showed that that an audit by the IRS documented twenty four percent…
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies…
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel’s…
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone’s huge debt crisis and economic slowdown. The country’s unemployment climbed to a huge twenty seven percent and the economy was still…
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in…
On Tuesday, tech giant Google released latest to show how much of its online traffic is…
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won’t seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said…
In a Tuesday announcement, Adobe revealed that it has...
With the computer business having witnessed steep losses...
In a scenario where the government of the nations are...
After the event that was the 'hot-news' of the week, the...
© 2024 AustrianTribune
